Texture analysis as a biomarker for Alzheimer's disease

Abstract

Background: In Alzheimer's disease (AD), conventional magnetic resonance imaging (MRI) biomarkers have focused on macroscopic neurodegeneration via atrophy assessment, but measurable volume changes tend to occur later in the disease process.